Substituted pyridoxazines

123 4 The invention provides compounds having the structure of formula I, and prodrugs, stereoisomers, racemates, salts, hydrates, solvates, acid salt hydrates and isomorphic crystalline forms thereof, wherein A, Y and the groups R, R, Rand Rare defined in the specification. These compounds can be a...

Full description

Saved in:
Bibliographic Details
Main Authors Newcom, Jason S, O'Connor, Stephen J, Gustafson, Gary R
Format Patent
LanguageEnglish
Published 14.06.2011
Online AccessGet full text

Cover

More Information
Summary:123 4 The invention provides compounds having the structure of formula I, and prodrugs, stereoisomers, racemates, salts, hydrates, solvates, acid salt hydrates and isomorphic crystalline forms thereof, wherein A, Y and the groups R, R, Rand Rare defined in the specification. These compounds can be administered in pharmaceutical formulations to modulate cannabinoid receptor activity for the prevention and treatment of a variety of diseases and conditions, including pain, inflammation and pruritis.